Business Context and Reporting Period
This Form 6-K filing by Ambev S.A. covers the month of February 2023, with the report signed on March 8, 2023. The filing is submitted pursuant to Rule 13a-16 of the Securities Exchange Act of 1934 and complies with Article 11 of CVM Instruction # 358/2002 regarding transactions with securities and derivatives.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory report on treasury share positions rather than a financial performance statement.
- Treasury Shares (Common): 8,482,160
- Treasury ADRs (Common): 0
Material Changes
No material changes in securities or derivatives positions occurred during the reporting month. The filing explicitly states that no securities and derivatives operations took place in February 2023. Consequently, the initial balance of treasury shares remained identical to the final balance.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items. The document is limited to reporting the absence of trading activity for the registrant's own securities.
Investor Verification Checklist
- Verify that no treasury share transactions occurred in February 2023 as declared.
- Confirm the total outstanding treasury shares remain at 8,482,160.
- Review subsequent filings for actual financial performance data, as this 6-K contains no operational metrics.